Resolvin D1/N-formyl peptide receptor 2 ameliorates paclitaxel-induced neuropathic pain through the activation of IL-10/Nrf2/HO-1 pathway in mice

INTRODUCTION: Paclitaxel is a chemotherapy drug that is commonly used to treat cancer, but it can cause paclitaxel-induced neuropathic pain (PINP) as a side effect. Resolvin D1 (RvD1) has been shown to be effective in promoting the resolution of inflammation and chronic pain. In this study, we evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Cun-Jin, Zhang, Jiang-Tao, Zhao, Feng-Lun, Xu, De-Lai, Pan, Jie, Liu, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040838/
https://www.ncbi.nlm.nih.gov/pubmed/36993950
http://dx.doi.org/10.3389/fimmu.2023.1091753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040838/
https://www.ncbi.nlm.nih.gov/pubmed/36993950
http://dx.doi.org/10.3389/fimmu.2023.1091753

Ejemplares similares